Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2026)

Biodesix (BDSX) has 8 years of Other Non-Current Liabilities data on file, last reported at $860000.0 in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 24.28% year-over-year to $860000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $860000.0 (up 24.28% YoY) and the FY2025 annual result came in at $1.0 million, up 25.28% from the prior year.
• Other Non-Current Liabilities fell to $860000.0 in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $12.3 million in Q2 2023 to a low of $60000.0 in Q3 2022.
• A 5-year average of $2.0 million and a median of $712000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 95.95% — and 2023, when it surged 17475.71%.
• Tracing BDSX's Other Non-Current Liabilities over 5 years: stood at $558000.0 in 2022, then gained by 27.6% to $712000.0 in 2023, then gained by 14.47% to $815000.0 in 2024, then rose by 25.28% to $1.0 million in 2025, then slipped by 15.77% to $860000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $860000.0 (Q1 2026), $1.0 million (Q4 2025), and $769000.0 (Q3 2025), per Business Quant data.